Tuesday, October 08, 2019 7:32:21 PM
The trial is not a lie, it was not a failure, CELZ is not hiding anything as you have stated. When the paper is reviewed and published we will all see who is right, and who is misleading whom.
We will absolutely see more offices open, more doctors trained and revenue increase. You will see that these first doctors treating with CaverStem were the first brilliant ones to see the future, to see the fix, to see patients healed that could not be helped otherwise. That is all there for those who choose to look and see it. They are not frauds, simple as that.
CELZ PPS is a joke. The IP alone is worth far far more that the current market cap. CELZ is a slow developing company, and not what the OTC likes. Doesn’t make it a scam. That’s the one thing you have right, the market doesn’t like what it sees. Not enough news events, poor choices in financing that came back to bite them. The note you quoted that was over on the 14th...., all true when I posted it and you know it. That was the worst one with the worst conversions. Dead on that day just like I posted. Same thing with the next one that died on September 20th or so. Are there a few more that could convert? Yep. But they could be paid off too. None of us know. Those same factors that make this market cap and PPS a joke, make the stock a good gamble. There is very very little room below, a huge chance to run back where it belongs. I still add every chance I get.
There is irrefutable evidence that CaverStem has been wildly successful so far and as soon as the paper is published, CELZ will be free to capitalize on it. It won’t just be the participating doctors talking about their successes, it will be proven by the paper as well. It’s not a scam with fake needles and photo shopped advertising as some claim.
The run back up could start tomorrow, or months from now....... I have no idea. You should have quoted me where I said it’s a marathon, not a race. Longs will win the marathon. There is no stopping CELZ. When the paper is out and the real fun starts, the SS will be meaningless. We have all seen larger SS companies run from sub penny to $. CELZ has all the IP locked up to be the best one yet.
It’s all a matter of when, not if......IMHO of course. I watch the board because I am an investor and sees what CELZ’s potential is. Funny why so many others post. Makes ya go hmmmmmm. My one donation to you this month. Enjoy.
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM